Last reviewed · How we verify
L-Methyl Folate and methylcobalamine
At a glance
| Generic name | L-Methyl Folate and methylcobalamine |
|---|---|
| Sponsor | Alexandria University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms. (NA)
- Efficacy of L-methylfolate and Methylcobalamine in Treating Resistant Hypertension Associated with Elevated Serum Homocysteine in Hemodialysis Patients. (PHASE4)
- Combination Therapy of Different Antidepressants With Dietary Supplements (NA)
- An Exploratory Investigation of a Supplement to Promote Cognitive Health Benefits (NA)
- Eat2beNICE Vitamins and Nutrients as Supplementation for Impulsivity, Irritability, and Compulsivity (NA)
- Restoration of Cutaneous Sensorum in Patients With Diabetic Peripheral Neuropathy (DPN) Via Metanx® (NA)
- NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)
- Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- L-Methyl Folate and methylcobalamine CI brief — competitive landscape report
- L-Methyl Folate and methylcobalamine updates RSS · CI watch RSS
- Alexandria University portfolio CI